Daniel J. O'Connor
2019 - OncoSec Medical
In 2019, Daniel J. O'Connor earned a total compensation of $1.2M as President and Chief Executive Officer at OncoSec Medical, a 72% decrease compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Salary | $453,846 |
| Stock Awards | $450,075 |
| Other | $22,800 |
| Total | $1,176,721 |
O'Connor received $453.8K in salary, accounting for 39% of the total pay in 2019.
O'Connor also received $250K in bonus, $450.1K in stock awards and $22.8K in other compensation.
Rankings
In 2019, Daniel J. O'Connor's compensation ranked 8,523rd out of 13,971 executives tracked by ExecPay. In other words, O'Connor earned more than 39.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,523 out of 13,971 | 39th |
Division Manufacturing | 3,381 out of 5,701 | 41st |
Major group Chemicals And Allied Products | 1,283 out of 2,200 | 42nd |
Industry group Drugs | 1,092 out of 1,886 | 42nd |
Industry Pharmaceutical Preparations | 811 out of 1,398 | 42nd |
Source: SEC filing on April 30, 2020.
O'Connor's colleagues
We found one more compensation record of an executive who worked with Daniel J. O'Connor at OncoSec Medical in 2019.
2019
Sara Bonstein
OncoSec Medical
Chief Financial Officer
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018